Tafenoquine - anti TB drug has been approved in July 2018 for: (A) Radicle cure of P falciparum, (B) Radicle cure of P vivax, (C) Clinical cure of P falciparum, (D) Clinical cure of P vivax
Answer is B. orally active 8 amino qinolone. It is a heame polymerase inhibitor. it is a prodrug and is active againist all liver forms includung hypnozoits. Molucular target is not exactly kmown